Colby Stong

A study was conducted to determine the effect of history of cardiovascular conditions on severity of COVID-19 infection in pediatric patients.

Investigators sought to develop and validate the COVID-HEART predictor to determine risk for adverse events in patients hospitalized with COVID-19.

Researchers evaluated the occurrence of adverse events following COVID-19 vaccination with mRNA- and vector-based vaccines, inactivated vaccines, DNA vaccines, and protein subunit vaccines.

Investigators examined the prevalence, clinical impact, and associations of pericardial involvement in patients hospitalized for treatment for COVID-19.

The American College of Cardiology has published guidelines for managing adult patients with cardiovascular sequelae after COVID-19 infection.

Researchers assessed independent predictors of all-cause mortality within a 2-year period among adult patients admitted to an emergency department with suspected bacterial infections.

Investigators assessed whether alterations in gut microbiome composition were linked to postacute COVID-19 syndrome.

Researchers sought to assess longitudinal interrelationships between changing white matter hyperintensities, cognition, and function after stroke.

Researchers sought to summarize scientific data on ocular surface disease in patients with atopic dermatitis receiving treatment with dupilumab.

Researchers sought to assess the prevalent use of antihypertensive medication regimens that stimulate vs inhibit type 2 and 4 angiotensin II receptors on the risk for mild cognitive impairment or dementia.